Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Compass Diversified (NYSE: CODI) finalized the sale of its majority-owned subsidiary Sterno's food service business to Archer Foodservice Partners for approximately $280 million after adjustments. The proceeds will be used to repay senior secured debt, reducing the company's net leverage ratio to below 1.0x by June 30, 2026, avoiding fees related t…
Global Business Travel Group's stock leapt after reports that Long Lake Management, an entity backed by General Catalyst Partners, is in advanced discussions to acquire the company at about $9.50 per share, a roughly 60% premium to the prior close. While sources say a deal could be announced quickly, no agreement is finalized and negotiations may s…
Barclays analysts argue that making quarterly financial statements optional could relieve short-term scrutiny for U.S. packaged food companies, aligning public reporting cadence with the multi-year nature of brand building, innovation payback, and portfolio reshaping. The SEC is reviewing a proposal that would allow companies to choose semi-annual …
Xanadu Quantum Technologies' stock plunged 55% Monday morning following a securities filing that registers 293.6 million Class B Subordinate Voting Shares for resale by selling securityholders. The registration also covers additional shares tied to warrant exercises and private placements. The company said it will receive proceeds only from any cas…
SOLV Energy, a Nasdaq-listed infrastructure services provider for the power industry, will release its first quarter 2026 financial results on May 12, 2026, followed by a management conference call and webcast. The company specializes in engineering, procurement, construction, operations, maintenance, and repowering of power infrastructure.
NextCure, Inc. in partnership with Simcere Zaiming Pharmaceutical have initiated the dose optimization phase of their Phase 1 clinical trial for SIM0505, an antibody drug conjugate targeting cadherin-6 for treating platinum-resistant ovarian cancer. SIM0505 has received Fast Track designation from the FDA, and the companies are expanding their clin…
Morgan Stanley’s AlphaWise 1H26 China CIO Survey of 60 chief information officers reports Alibaba emerging as the clear frontrunner in China’s AI landscape, with its Qwen model consolidating across cloud, models and applications. The survey also shows a marked slowdown in expected IT budget growth for 2026, growing allocation to AI within IT budget…
Pasithea Therapeutics, a US-based clinical-stage biotech company, announced the appointment of Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer. Dr. Krishnan brings extensive experience in clinical development, particularly with MEK inhibitors, having contributed to the FDA approval of cobimetinib. He will oversee clinical strategy for PAS-00…
Indivior Pharmaceuticals announced a $175 million accelerated share repurchase agreement with Barclays, utilizing part of its ongoing $400 million buyback program. The company aims to demonstrate confidence in its long-term strategy and financial strength without altering prior financial guidance. The ASR will initially repurchase 3.7 million share…
Axsome Therapeutics reported a robust first quarter of 2026 with total net product revenue growing 57% year-over-year to $191.2 million. The company highlighted the FDA approval of Auvelity for agitation associated with dementia due to Alzheimer's disease, positioning it as a first-in-class treatment. Axsome expanded its commercial efforts and adde…
Superior Group of Companies, Inc. reported its Q1 2026 results showing net sales increase to $140.9 million from $137.1 million a year ago, with net income turning positive at $0.8 million compared to a net loss previously. EBITDA rose to $4.8 million. The company confirmed its full-year 2026 sales and earnings outlook with net sales expected betwe…
ADMA Biologics announced that the FDA has approved the supplemental Biologics License Application for ASCENIV™, expanding its indication for primary humoral immunodeficiency (PI) to include pediatric patients aged two years and older, down from twelve years. This approval follows the final pediatric assessment study report, fulfilling post-marketin…
Seer, Inc. announced the hiring of Anthony Bazarko as Chief Commercial Officer. Bazarko brings over 20 years of leadership experience in life sciences and diagnostics, including prior executive roles at Biologos and Specific Diagnostics. At Seer, he will lead Sales, Marketing, and Customer Experience to boost adoption of Seer's Proteograph® Product…
SOLV Energy announced its agreement to acquire Roberson Waite Electric, a California-based utility substation construction and services provider. This acquisition expands SOLV’s capabilities into the regulated utility market, enhancing its service offerings in grid modernization and resilience, and supports its long-term growth strategy.
Haleon, a global consumer health leader, has introduced the newly reformulated Centrum Adults 50+ Complete Multivitamin in Canada, designed to support nutritional needs and cognitive health of adults aged 50 and over. The formulation is backed by clinical trials demonstrating memory and brain health benefits, continuing Haleon's commitment to scien…
Seres Therapeutics announced preclinical data supporting SER-603, a novel live biotherapeutic candidate designed to target microbial functions linked to mucosal healing and inflammation in inflammatory bowel disease (IBD). Presented at Digestive Disease Week 2026, the data demonstrate SER-603’s potential for precise modulation of inflammatory pathw…
Tilray's craft beer brand 10 Barrel Brewing introduces two new ready-to-drink cocktails—Clean Slate, a non-alcoholic functional beverage infused with vitamins and natural energizers, and Salty Sips, a low-sugar, low-ABV vodka cocktail. These products target changing consumer preferences towards functional, health-conscious drinks and aim to expand …
Prospect Capital Corporation, a US-based business development company, has completed a $26 million investment in Security Fire Systems, collaborating with Blackford Capital. The investment includes a senior secured term loan and preferred equity to finance SFS's growth and acquisition plans in the fire suppression industry across multiple states an…
Krystal Biotech announced robust financial results for Q1 2026, including a 32% increase in global revenue for its gene therapy product VYJUVEK, totaling $116.4 million. The company completed enrollment in a key ophthalmology clinical study and is on track for multiple registrational data readouts this year. It also received FDA platform technology…
Legence Corp. plans to release its first quarter 2026 financial results on May 14, 2026 before market open. The company will host a webcast and conference call to discuss the results and operations with investors and the public. The webcast and related materials will be available on Legence's investor relations website, with a replay accessible for…
Cibus, Inc. has transferred gene-edited herbicide tolerance traits in rice to its partner Interoc to begin testing and production, ahead of planned commercialization in Latin America. The collaboration leverages Cibus' rapid trait development technology to address agricultural productivity and sustainability, with further gene-edited traits expecte…
Tenax Therapeutics has named Timothy Healey as their new Chief Commercial Officer. He brings substantial pharmaceutical commercial leadership experience, having led successful drug launches at prominent biopharma companies. Healey will oversee the global commercial strategy and prepare the company for the launch of TNX-103, an innovative therapy be…
BioCryst Pharmaceuticals has entered into an exclusive licensing agreement with Neopharmed Gentili's Irish affiliate granting rights to commercialize navenibart, a Phase 3 investigational treatment for hereditary angioedema, in Europe. The deal includes $70 million upfront, up to $275 million in milestone payments, and tiered royalties, strengtheni…
Hewlett Packard Enterprise is positioned to capture outsized AI-driven infrastructure spending through new products, partner momentum and improving profitability. Recent results and raised EPS guidance support a long bias. This trade sets an entry at $28.58, stop at $26.00 and a $34.00 target with timeframes for short, mid and long-horizon plays.
Fervo Energy has submitted a registration for an initial public offering, proposing the sale of 55,555,555 Class A shares at an anticipated price range of $21.00 to $24.00 each. The Houston geothermal developer intends to list on NASDAQ under the ticker FRVO and will retain a dual-class capital structure after the offering, with founders Tim Latime…
